Download File

Description:

ACC.18 Presentation Slides | ODYSSEY Outcomes: CV Outcomes With Alirocumab After ACS

Date: March 10, 2018    

Keywords: ACC18 Slides, ACC Annual Scientific Session, Angina, Stable, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Acute Coronary Syndrome, Maximum Tolerated Dose, Brain Ischemia, Stroke, Antibodies, Monoclonal, Angina, Unstable, Apolipoproteins B, Myocardial Infarction, Coronary Disease, Treatment Outcome, Hospitalization, Subtilisins